Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A ceRNA network-mediated over-expression of cuproptosis-related gene SLC31A1 correlates with poor prognosis and positive immune infiltration in breast cancer

18 May 2023

Abstract excerpt

Introduction Solute carrier family 31 member 1(SLC31A1) has been reported as the copper importer, and was identified to be involved in the process of “cuproptosis”. However, the mechanism of SLC31A1 in breast cancer remains unclear. Methods We examined the expression of SLC31A1 mRNA in breast cancer tissues and cell lines using Real-time PCR. The data for this study were obtained from The Cancer Genome Atlas...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ferroptosis and cancer prognosis
Share to MicroRNA in disease regulation
Share to Trace Elements in Health

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37275369
DOI: 10.3389/fmed.2023.1194046

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A ceRNA network-mediated over-expression of cuproptosis-related gene SLC31A1 correlates with poor prognosis and positive immune infiltration in breast cancerPMID 37275369Read ↗

Cuproptosis-related gene SLC31A1: prognosis values and potential biological functions in cancerSemantic proximity Read ↗

Identification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancerSemantic proximity Read ↗

Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor typesSemantic proximity Read ↗

Systematic Pan-Cancer Analysis Identifies SLC31A1 as a Biomarker in Multiple Tumor TypesSemantic proximity Read ↗

SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-CancerSemantic proximity Read ↗

Comprehensive Pan-cancer Analysis of Cuproptosis-related Gene SLC31A1 as a Potential Biomarker for Cancer Survival and ImmunotherapySemantic proximity Read ↗

Transcriptome profiling reveals cuproptosis heterogeneity in triple-negative breast cancerSemantic proximity Read ↗

Construction of a prognostic model based on cuproptosis-related patterns for predicting survival, immune infiltration, and immunotherapy efficacy in breast cancerSemantic proximity Read ↗

Cuproptosis-related Gene Slc31a1 Expression Correlates With the Prognosis and Tumor Immune Microenvironment in GliomaSemantic proximity Read ↗

Exploration of cuproptosis-Related Long Non-Coding RNA Signature to predict the clinical outcome and Immune Microenvironment in Cervical CancerSemantic proximity Read ↗

Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in gliomaSemantic proximity Read ↗

Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a potential regulator of cuproptosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.